Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyLymphomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.
A MyLymphomaTeam Member asked a question 💭
Estero, FL
January 25, 2025
 · 
Reactions
MyLymphomaTeam

The best treatment for CD20+ lymphoma often involves monoclonal antibodies targeting the CD20 protein. Rituximab is the most commonly used monoclonal antibody for B-cell non-Hodgkin lymphomas (NHLs) and nodular lymphocyte-predominant Hodgkin lymphoma (HL). Other options include Obinutuzumab (Gazyva) and Ofatumumab Show Full Answer

The best treatment for CD20+ lymphoma often involves monoclonal antibodies targeting the CD20 protein. Rituximab is the most commonly used monoclonal antibody for B-cell non-Hodgkin lymphomas (NHLs) and nodular lymphocyte-predominant Hodgkin lymphoma (HL). Other options include Obinutuzumab (Gazyva) and Ofatumumab (Arzerra), which are also effective for certain CD20+ lymphomas. These are often combined with chemotherapy for better outcomes. Always consult your doctor for personalized advice.

January 25, 2025
A MyLymphomaTeam Member

This is what has been recommended for me and I am so grateful that Fred Hutch, Seattle, recommended treatment when my local cancer center said treatment for me did not meet their protocols. Breathing a huge sigh of relief and hoping for best with them.. starting next week..

January 29, 2025

Related Questions

View All
Continue with Facebook
Continue with Google
By joining, you accept our Terms of Use, and acknowledge our collection, sharing, and use of your data in accordance with our Health Data and Privacy policies.
Already a member? Log In